Acelyrin, Inc. Profile Avatar - Palmy Investing

Acelyrin, Inc.

Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to…

Biotechnology
US, Agoura Hills [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of SLRN's Analysis
CIK: 1962918 CUSIP: 00445A100 ISIN: US00445A1007 LEI: - UEI: -
Secondary Listings
SLRN has no secondary listings inside our databases.